Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¼Ò¾Æ¿¡¼­ ¹ß»ýÇÑ Clostridium difficile °ü·Ã ÁúȯÀÇ ¿ªÇаú ÀÓ»ó¾ç»ó: Áö¿ª»çȸ°¨¿°°ú ¿ø³»°¨¿°ÀÇ ºñ±³ Epidemiology and Clinical Characteristics of Clostridium difficile-associated Disease in Children: Comparison between Community- and Hospital-acquired Infections

´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸÁö 2010³â 13±Ç 2È£ p.146 ~ 153
Á¶ÇýÁ¤, ·ùÀÏ, ¼±¿ëÇÑ, Á¶°­È£, ¼Õµ¿¿ì, Â÷ÇÑ,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¶ÇýÁ¤ ( Cho Hye-Jung ) 
°¡ÃµÀÇ°úÇдëÇб³ ÀÇÇÐÀü¹®´ëÇпø ¼Ò¾Æ°úÇб³½Ç

·ùÀÏ ( Ryoo Eell ) 
°¡ÃµÀÇ°úÇдëÇб³ ÀÇÇÐÀü¹®´ëÇпø ¼Ò¾Æ°úÇб³½Ç
¼±¿ëÇÑ ( Sun Yong-Han ) 
°¡ÃµÀÇ°úÇдëÇб³ ÀÇÇÐÀü¹®´ëÇпø ¼Ò¾Æ°úÇб³½Ç
Á¶°­È£ ( Cho Kang-Ho ) 
°¡ÃµÀÇ°úÇдëÇб³ ÀÇÇÐÀü¹®´ëÇпø ¼Ò¾Æ°úÇб³½Ç
¼Õµ¿¿ì ( Son Dong-Woo ) 
°¡ÃµÀÇ°úÇдëÇб³ ÀÇÇÐÀü¹®´ëÇпø ¼Ò¾Æ°úÇб³½Ç
Â÷ÇÑ ( Tchah Hann ) 
°¡ÃµÀÇ°úÇдëÇб³ ÀÇÇÐÀü¹®´ëÇпø ¼Ò¾Æ°úÇб³½Ç

Abstract

¸ñÀû: ÃÖ±Ù ¼Ò¾Æ¿¡¼­ÀÇ Áö¿ª»çȸ ȹµæ Clostridium difficile °ü·ÃÁúȯ(CDAD)Àº Áõ°¡ÇÏ´Â °ÍÀ¸·Î º¸°íµÈ´Ù. ±×·¯³ª ¾ÆÁ÷ ¼Ò¾Æ¿¡¼­ ¹ß»ýÇÑ CDAD¿¡ ´ëÇÑ Á¤º¸´Â ºÎÁ·ÇÑ ½ÇÁ¤ÀÌ´Ù. ÀúÀÚµéÀº ¼Ò¾Æ CDADȯÀÚ¿¡¼­ Áö¿ª»çȸ°¨¿°(CA-CDAD)°ú º´¿ø°¨¿°(HA-CDAD)ÀÇ ¿ªÇаú ÀÓ»ó¾ç»óÀÇ Â÷À̸¦ ºñ±³ÇÏ¿© ¾Ë¾Æº¸°íÀÚ ÇÏ¿´´Ù.

¹æ ¹ý: 2008³â 4¿ùºÎÅÍ 2010³â 3¿ù±îÁö °¡ÃµÀÇ´ë ±æº´¿ø ¼Ò¾Æû¼Ò³â°ú¿¡ ³»¿øÇÑ È¯ÀÚµéÀÇ Àǹ«±â·ÏÀ» ÈÄÇâÀûÀ¸·Î ºÐ¼®ÇÏ¿© ¼ÒÈ­±â°è Áõ»óÀ» °¡Áö°í ÀÖÀ¸¸é¼­ C. difficile µ¶¼Ò A, B ¶Ç´Â C. difficile ¹è¾ç°Ë»ç¿¡¼­ ¾ç¼ºÀ¸·Î È®ÀÎµÈ °æ¿ì CDAD·Î Áø´ÜÇÏ¿´´Ù.

°á °ú: ÃÑ 61¸í(³² 32, ¿© 29)ÀÇ È¯ÀÚ°¡ ¿¬±¸¿¡ Æ÷ÇԵǾú°í, Æò±Õ¿¬·ÉÀº 3.79¡¾4.54¼¼¿´À¸¸ç, 1¼¼ ¹Ì¸¸ÀÌ 22¸í(36.1%)À¸·Î °¡Àå ¸¹¾Ò´Ù. Àüü Áß 23¸í(37.7%)ÀÇ È¯ÀÚ¸¸ÀÌ Áõ»ó ¹ßÇö 3°³¿ù À̳»¿¡ Ç×»ýÁ¦¸¦ Åõ¿© ¹ÞÀº ÀûÀÌÀÖ¾ú´Ù. ÃÑ 61¸íÀÇ È¯ÀÚ Áß CA-CDAD±ºÀÌ 41¸í, HA-CDAD±ºÀÌ 20¸íÀ̾ú°í, ³ªÀÌ, ¼ºº°, Áõ»ó, °Ë»ç½Ç¼Ò°ß, ȸº¹±â°£, ÇÕº´Áõ ¹ß»ý ¹× Àç¹ß·üÀº µÎ ±º °£¿¡
À¯ÀÇÇÑ Â÷ÀÌ°¡ ¾ø¾úÀ¸³ª Ç×»ýÁ¦ ³ëÃâ ¿©ºÎ´Â HACDADÀÇ ¹ß»ý°ú °ü·ÃÀÌ ÀÖ¾ú´Ù.

°á ·Ð: ¼ÒÈ­±â°è Áõ»óÀ» °¡Áö°í ¿Ü·¡¿¡ ³»¿øÇÑ ¿µ¾Æ¿Í ¾î¸° ¼Ò¾Æ¿¡¼­ Ç×»ýÁ¦ ³ëÃâ·ÂÀÌ ¾ø´Â CA-CDADÀÇ ¹ß»ýÀÌ Áõ°¡ÇÏ°í ÀÖ´Ù. ½Å¼ÓÇÏ°Ô °Ë»ç¸¦ ½ÃÇàÇÏ´Â °ÍÀÌ Á¤È®ÇÑ Áø´Ü°ú Ä¡·á¸¦ À§ÇØ ¿ä±¸µÈ´Ù.

Purpose: Recent studies have reported an increase in the incidence of community-acquired Clostridium difficile-associated disease (CA-CDAD) among children. There is an overall lack of information on CA-CDAD in the pediatric population. The aim of our study was to compare the epidemiologic and clinical features between CA-CDAD and hospital-acquired C. difficile-associated disease (HA-CDAD) in children.

Methods: We retrospectively reviewed the medical records of all patients who were diagnosed with C. difficile-associated disease (CDAD) at Gil Hospital between April 2008 and March 2009. The diagnosis of CDAD was made when patients with gastrointestinal symptoms had positive results for C. difficile toxins A and B assay or stool culture.

Results: Sixty-one (male, 32 and female, 29) patients were included. The mean age was 3.79¡¾4.54 years. Of the 61 patients, 22 (36.1%) were £¼1 year of age. Twenty-three patients (37.7%) had a history of antibiotic exposure in the previous 3 months. Forty-one patients (67.2%) were diagnosed with CA-CDAD. There were no significant differences in age, gender, symptoms, laboratory findings, recovery period, complications, and recurrence between the CA-CDAD and HA-CDAD groups. On the other hand, exposure to antibiotics was significantly more frequent among patients in the HA-CDAD group (p=0.005).

Conclusion: This study suggests that the occurrence of CA-CDAD is increasing in the pediatric population, especially in younger children with no history of exposure to antibiotics and in outpatients. Awareness of the increasing incidence of CA-CDAD and prompt investigation of C. difficile in susceptible patients is needed to avoid misdiagnosis and for appropriate therapy.

Å°¿öµå

Clostridium difficile; Children; Diarrhea; Community-acquired infections; Nosocomial infections

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS